Corrigendum: Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond

Xiaoli Wang^{1

2}, Guoyi Li¹, Jingkang Guo², Zhiping Zhang², Shuzhang Zhang², Yudan Zhu¹, Jiwei Cheng¹, Lu Yu¹, Yonghua Ji^{2

3}, Jie Tao^{1

4}

Affiliations

¹ Department of Neurology and Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
² Institute of Biomembrane and Biopharmaceutics, Shanghai University, Shanghai, China.
³ Xinhua Translational Institute for Cancer Pain, Shanghai, China.
⁴ Putuo Clinical Medical School, Anhui Medical University, Shanghai, China.

Published Erratum

Xiaoli Wang et al. Front Neurosci. 2020.

. 2020 Feb 28:14:163.

doi: 10.3389/fnins.2020.00163. eCollection 2020.

Xiaoli Wang^{1

2}, Guoyi Li¹, Jingkang Guo², Zhiping Zhang², Shuzhang Zhang², Yudan Zhu¹, Jiwei Cheng¹, Lu Yu¹, Yonghua Ji^{2

3}, Jie Tao^{1

4}

¹ Department of Neurology and Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
² Institute of Biomembrane and Biopharmaceutics, Shanghai University, Shanghai, China.
³ Xinhua Translational Institute for Cancer Pain, Shanghai, China.
⁴ Putuo Clinical Medical School, Anhui Medical University, Shanghai, China.

Abstract

[This corrects the article DOI: 10.3389/fnins.2019.01393.].

Keywords: Alzheimer's disease; Kv1.3; Parkinson's disease; ShK; epilepsy; multiple sclerosis; neuroinflammatory disease; stroke.

Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond.
Wang X, Li G, Guo J, Zhang Z, Zhang S, Zhu Y, Cheng J, Yu L, Ji Y, Tao J. Wang X, et al. Front Neurosci. 2020 Jan 14;13:1393. doi: 10.3389/fnins.2019.01393. eCollection 2019. Front Neurosci. 2020. PMID: 31992966 Free PMC article. Review.